ENLV
ENLV
NASDAQ · Biotechnology

Enlivex Therapeutics Ltd

$1.20
-0.17 (-12.41%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +2,962.5% upside
Low Target $26.33
Average Target $36.75
High Target $40.94
Current Price $1.20
Current
$1.20
Target
$36.75
$26.33 $36.75 avg $40.94
Scenario Analysis
Bear Case
$26.33
2,094.2%
Low target
Base Case
$36.75
+2,962.5%
Avg target
Bull Case
$40.94
+3,311.7%
High target
Risk/Reward
1.6x
Balanced
Price in Context
Target vs 52W High
$36.75
-91.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.5%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.4%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -18.5%
MRNA
Moderna Inc
Hold 31 32% $149.45 -35.4%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.7%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -35.3%